Table 3.
Clinical outcome data
| Characteristics | Paracetamol |
Additional control group sucrose 24% (n = 20) | ||
|---|---|---|---|---|
| 10 mg/kg (n = 20) | 15 mg/kg (n = 20) | 20 mg/kg (n = 20) | ||
| RDS | 15 (75) | 16 (80) | 13 (65) | 14 (70) |
| Mechanical ventilation | 15 (75) | 16 (80) | 14 (70) | 13 (65) |
| Surfactant | 14 (70) | 15 (75) | 14 (70) | 13 (65) |
| PDA | 8 (40) | 7 (35) | 12 (60) | 8 (40) |
| Treatment indomethacin | 3 (15) | 2 (10) | 5 (25) | 0 |
| Treatment ibuprofen | 2 (10) | 3 (15) | 4 (20) | 8 (40) |
| Surgery | 5 (25) | 2 (10) | 4 (20) | 1 (5) |
| Sepsis | 9 (45) | 9 (45) | 10 (50) | 12 (60) |
| NEC | 1 (5) | 1 (5) | 2 (10) | 1 (5) |
| FIP | 0 | 2 (10) | 2 (10) | 0 |
| Surgery NEC | 0 | 1 (5) | 3 (15) | 1 (5) |
| IVH | 2 (10) | 5 (25) | 6 (30) | 4 (20) |
| Death | 0 | 4 (20) | 2 (10) | 2 (10) |
Values are presented as n (%). RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; NEC, necrotizing enterocolitis; FIP, focal intestinal perforation; IVH, intraventricular hemorrhage.